Chronic kidney disease (CKD) affects more than 1 in 7 American adults and, with end-stage kidney disease (ESKD), accounts for billions of dollars in health care costs. Current treatment isn’t optimal — resulting in high costs and poor health outcomes. That’s why it’s time to rethink how you manage your kidney disease population.
There are substantial avoidable costs for health insurance providers that are able to safely help members delay dialysis, decrease the number of expensive, unplanned starts to dialysis, and get more people on a home-based modality. Successfully doing so demands a cohesive solution like the dedicated solution from CVS Kidney Care.
CVS Kidney Care
Jelka is Vice President of Business Development for CVS Kidney Care. She’s passionate about changing the status quo of our health care system by creating innovative, collaborative health care models between providers, payers and employers. Her focus is to improve the lives of the patients we serve.
Before joining CVS Kidney Care, Jelka led the strategy, provider negotiations and implementation of innovative value-based programs for hospital systems within Aetna’s Joint Ventures Strategy and Innovation team. Her health care career spans over 30 years and includes leadership and executive experience with payer and provider organizations. She served in executive roles in underwriting, operations, marketing, product development and sales.
Jelka received her BS in Economics with a minor in Finance from Wayne State University. She also completed several certification programs in managed care and health care consulting.
Bruce Culleton, M.D.
Vice President and Chief Medical Officer
CVS Kidney Care
Bruce Culleton provides medical oversight and guidance to all strategic initiatives for CVS Kidney Care. Before joining CVS Health in 2017, he spent more than 10 years in the medical device industry in a variety of global medical affairs and clinical development roles. He has also worked as an academic nephrologist and has published more than 100 scientific papers related to chronic kidney disease, dialysis and clinical practice guidelines.
Bruce received his medical degree and fellowship diplomas in internal medicine and nephrology from the Royal College of Canada. He also earned a fellowship diploma in clinical epidemiology from the Framingham Heart Study and an MBA from the Kellogg School of Management at Northwestern University.